ask="2.55"
ask_size="2000"
average_daily_volume="131798"
bid="N/A"
bid_size="N/A"
book_value="1.40"
change="-0.01"
change_from_200_day_moving_average="1.47"
change_from_50_day_moving_average="0.69"
change_from_52_week_high="-5.30"
change_From_52_week_low="0.62"
change_in_percent="-0.39%"
close="2.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-2.11M"
eps_estimate_current_year="-0.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.02"
ex_dividend_date="N/A"
float_shares="2160000"
high="2.55"
high_52_weeks="7.85"
last_trade_date="3/16/2017"
last_trade_price="2.55"
last_trade_size="498"
last_trade_time="4:00pm"
low="2.50"
low_52_weeks="1.93"
market_capitalization="6.83M"
moving_average_200_day="1.08"
moving_average_50_day="1.86"
name="XTL Biopharmaceuticals Ltd."
notes="N/A"
one_year_target_price="30.00"
open="2.54"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+136.54%"
percent_change_from_50_day_moving_average="+36.89%"
percent_change_from_52_week_high="-67.51%"
percent_change_from_52_week_low="+32.12%"
previous_close="2.56"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.83"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="2680000"
short_ratio="0.06"
stock_exchange="NCM"
symbol="XTLB"
volume="27697"
weeks_range_52="1.93 - 7.85"
